© 2020 Palmetto GBA, LLC
We frequently update our articles to reflect the latest changes and updates to Medicare, and strongly recommend you visit this article at link below to confirm you have the latest version.
Printed Date: 9/22/2015
Answer: Harry Feliciano, M.D., MPH, is Palmetto GBA's Senior Medical Director responsible for all coverage policy activities at Palmetto GBA. Dr. Feliciano is also the lead Contractor Medical Director for home health and hospice coverage policy. His specialties are geriatrics and public health. Dr. Feliciano brings to Palmetto GBA an intense interest in implementing new approaches to improving provider-payer communications and performance based on the principles of Lean Six Sigma.
Antonietta (Toni) Sculimbrene, M.D., MHA, works with Dr. Feliciano and serves as the lead Contractor Medical Director for Part A and Part B coverage policy. Dr. Sculimbrene is an anesthesiologist and pharmacist by training and has served as medical director at several health insurers, most recently at Blue Cross and Blue Shield of Vermont. She brings to Palmetto GBA expertise in evidence-based policy development, quality improvement, and ICD-10.
Leland E. Garrett M.D., FACP, FASN, CPC, works with Dr. Feliciano and Dr. Sculimbrene and serves as a Contractor Medical Director for Part A and Part B coverage policy. Dr. Garrett is a nephrologist and internist by training. Before coming to Palmetto GBA, he served for 20 years as a physician in the United States Air Force, was in private practice in Raleigh North Carolina for 20 years and then was a Medical Director for Blue Cross and Blue Shield of North Carolina in the Medicare Advantage and Medicare Part D Programs and subsequently the Special Investigations Unit. He is a Fellow of the American College of Physicians, a Fellow of the American Society of Nephrology and a certified coder.
Dr. Gabriel Alejandro Bien-Willner, M.D., Ph.D., is the Medical Director of the MolDX program at Palmetto GBA, which seeks to understand the molecular testing landscape to implement payer controls, coverage, and to set policy. He is a leader in the Precision Medicine space and practices as a board-certified Anatomic Pathologist and Molecular Genetic Pathologist. Dr. Bien-Willner received his M.D. and Ph.D. from Baylor College of Medicine, with a doctorate in Human Molecular Genetics. His clinical training and academic tenure was at Washington University in St. Louis. Throughout his career, he has been active in research, development, and advancement of molecular diagnostic services, specifically next-generation sequencing. His experience spans both academia and industry. He has worked closely with clinicians to develop clear clinical diagnostic and treatment pathways directing Precision Medicine programs for community cancer centers.
We value your opinion and want to provide the highest-quality and most relevant Medicare knowledge possible. Please let us know if this article was helpful.
It didn't answer my question
This article was helpful
We’re glad we could help you today and appreciate your feedback. When you rate our articles as most helpful, we know that we are on the right track for providing you with important news and information.
We're sorry this article didn't help you today. We'll use your feedback to review this article to try to revise or expand it. Contact us with more feedback or a question on this topic.
Last Updated: 07/22/2020